Close Menu

A team led by Tokyo Medical University researchers have identified a microRNA that regulates extracellular vesicle (EV) secretion from prostate cancer cells, offering a potential new therapeutic target for the disease. Given the role of aberrant miRNA expression in cancer and the importance of EVs to cancer progression, the scientists screened thousands of miRNAs using ExoScreen, a liquid biopsy technique they previously developed for detecting disease-specific EVs.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.